Company Description
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.
The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting.
It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders designed to record and store EEG signals generated by the headband.
In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient’s EEG data.
The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.
CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Country | United States |
Founded | 2014 |
IPO Date | Oct 11, 2024 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 281 |
CEO | Xingjuan Chao |
Contact Details
Address: 360 North Pastoria Avenue Sunnyvale, California 94085 United States | |
Phone | (800) 436-0826 |
Website | ceribell.com |
Stock Details
Ticker Symbol | CBLL |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $17.00 |
CIK Code | 0001861107 |
ISIN Number | US15678C1027 |
Employer ID | 47-1785452 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Dr. Xingjuan Chao Ph.D. | Co-Founder, President, Chief Executive Officer and Director |
Dr. Josef Parvizi M.D., Ph.D. | Co-Founder, Chief Medical Advisor and Director |
Scott Blumberg | Chief Financial Officer |
Dr. Raymond Woo Ph.D. | Chief Technology Officer |
Joshua Copp | Chief Business Officer |
Dan Rogy | Senior Vice President of Operations |
Louisa Daniels J.D., M.B.A. | General Counsel |
Sean Manni | Senior Vice President of Sales |
Brian P. Price | Senior Vice President of Marketing |
Kristie Rodenbush | Chief People Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 14, 2025 | 8-K | Current Report |
Feb 25, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
Feb 25, 2025 | 10-K | Annual Report |
Feb 25, 2025 | 8-K | Current Report |
Feb 20, 2025 | SCHEDULE 13G | Filing |
Feb 14, 2025 | SCHEDULE 13G | Filing |
Feb 13, 2025 | SCHEDULE 13G | Filing |
Feb 12, 2025 | SCHEDULE 13G | Filing |
Feb 12, 2025 | SCHEDULE 13G | Filing |
Jan 13, 2025 | 8-K | Current Report |